A Study of Elotuzumab With Pomalidomide, Bortezomib, and Dexamethasone in Relapsed Multiple Myeloma

NCT02718833 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Elotuzumab
DRUG: Pomalidomide
DRUG: Bortezomib
DRUG: Dexamethasone

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]
[object Object]